DR info

Clinical trials : 18 / Drugs : 15 - (DrugBank : 8) / Drug target genes : 10 - Drug target pathways : 17

Spinal and bulbar muscular atrophy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
1	Spinal and bulbar muscular atrophy
2	Amyotrophic lateral sclerosis
46	Malignant rheumatoid arthritis
113	Muscular dystrophy
86	Pulmonary arterial hypertension
96	Crohn disease
6	Parkinson disease
13	Multiple sclerosis/Neuromyelitis optica
256	Muscle glycogenosis
231	Alpha-1-antitrypsin deficiency
168	Ehlers-Danlos syndrome
53	Sjogren syndrome
70	Spinal stenosis
51	Scleroderma
10	Charcot-Marie-Tooth disease
38	Stevens-Johnson syndrome
114	Non-dystrophic myotonia syndrome
127	Frontotemporal lobar degeneration
58	Hypertrophic cardiomyopathy
140	Dorabe syndrome
36	Epidermolysis bullosa
144	Lennox-Gastaut syndrome
193	Prader-Willi syndrome
107	Juvenile idiopathic arthritis
298	Hereditary pancreatitis
226	Interstitial cystitis with Hunners ulcer
28	Systemic amyloidosis
156	Rett syndrome
84	Sarcoidosis
8	Huntington disease
34	Neurofibromatosis
97	Ulcerative colitis
3	Spinal muscular atrophy
111	Congenital myopathy